Physician profile
Michael Wayne Brown
NPI 1477507705
$4,816.63
in general payments reported to CMS, 2019-2025
39 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,352 · 2020: $418 · 2021: $874 · 2022: $863 · 2023: $603 · 2024: $553 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,310.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,186.69 | 2019-2024 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $481.92 | 2019-2022 | |
| Allergan, INC. | $348.37 | 2019-2022 | |
| Abbvie INC. | $326.13 | 2019-2025 | Botox |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.44 | 2019-2020 | |
| Boston Scientific Corporation | $178.66 | 2019-2024 | Rezum Generator, Ams 700 Cxr Rte Kit |
| Coloplast Corp | $168.18 | 2019-2024 | |
| Procept Biorobotics Corporation | $156.00 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Rochester Medical Corporation | $154.02 | 2019-2021 | |
| Tolmar Pharmaceuticals, INC. | $152.22 | 2019-2021 | |
| Medtronic, INC. | $138.46 | 2021-2025 | Interstim |
| Sumitomo Pharma America, INC. | $125.40 | 2023-2024 | Gemtesa |
| Endo Pharmaceuticals INC. | $121.67 | 2019-2024 | Xiaflex |
| Verity Pharmaceuticals INC. | $100.82 | 2022-2025 | Tlando, Trelstar |
| Pfizer INC. | $99.37 | 2019-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $96.38 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $94.44 | 2019-2020 | |
| Antares Pharma, INC. | $81.54 | 2022-2023 | Xyosted, Tlando, Nocdurna |
| Axonics, INC. | $68.68 | 2022-2023 | Axonics, Bulkamid |
| Olympus America INC. | $61.44 | 2024-2025 | Itind System, Olympus, Bovie |
| Halozyme INC | $50.36 | 2023 | |
| Urogen Pharma, INC. | $46.33 | 2021-2022 | |
| Blue Earth Diagnostics | $44.46 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $41.57 | 2021-2022 | |
| Travere Therapeutics, INC. | $37.59 | 2019-2022 | |
| Urovant Sciences INC | $37.18 | 2021-2022 | |
| Tolmar, INC. | $23.14 | 2023 | |
| Conmed Corporation | $22.54 | 2023 | Airseal |
| Calyxo, INC. | $21.96 | 2024 | Cvac Aspiration System |
| Mission Pharmacal Company | $20.65 | 2023 | Uribel |
| Accord Healthcare, INC. | $20.41 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.03 | 2021 | |
| Abbott Laboratories | $18.29 | 2022 | |
| Ethicon US, LLC | $17.40 | 2021 | |
| Myriad Genetic Laboratories, INC. | $15.96 | 2023 | Prolaris |
| Novo Nordisk INC | $15.90 | 2024 | |
| Zyla Life Sciences, INC. | $15.22 | 2019 | |
| Myovant Sciences INC. | $13.37 | 2021 | |
| Aytu Biopharma, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.